SARS-CoV-2 Genome Sequencing Service
The COVID 19 pandemic has had an unprecedented impact on society. It has also highlighted the incredible collaborative work by the global scientific community in developing vaccines so quickly. Now with multiple vaccination programmes underway there is light at the end of the tunnel.
However, there is a risk of new vaccine-resistant variants of the novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) emerging. With this specific challenge in mind we have developed a SARS-CoV-2 genome sequencing service to enable researchers to identify variants for further phylogenetic analysis of related strains. This research can then be used to inform and optimise pandemic management strategies.
The service is available from our Cambridge Sequencing Centre. The centre is equipped with the latest NovaSeq 6000 sequencers and supported by our expert and friendly team.
To find out how we can help you, complete the form below and we will be in touch.